Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.
Over-the-counter (OTC) medicines are nonprescription medications that individuals can purchase directly without a doctor's prescription. OTC drugs effectively treat various disorders and their associated symptoms, including pain, coughs, colds, diarrhea, constipation and acne. Vitamins and dietary supplements are intended to provide essential nutrients to fill potential gaps in a person's diet for maintaining an active and healthy lifestyle. Common dietary supplements include vitamins, minerals, herbs and botanicals, probiotics, fish oil and more. To capture product-specific nuances, this report, where relevant, treats the OTC drugs market as being distinct from the vitamins and drug supplement market in its analysis.
Key players in the global OTC drugs, vitamins and dietary supplements market include Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer, Procter & Gamble, Reckitt, STADA Arzneimittel AG, Amway, Nestle, Pharmavite, H&H Group, Herbalife, Church & Dwight and GNC Holdings. The market is highly fragmented. In addition to industry leaders, domestic players and store brands also play a vital role. Companies compete in terms of pricing strategies, product quality, innovation, brand recognition and distribution channels.
Segmental Analysis
In this report, the global OTC drugs, vitamins and dietary supplements market is segmented based on product type, point of sale and geographic region. Whereas vitamins and dietary supplements are treated as their own product type segment, OTC drugs are further segmented by product type into respiratory treatments, pain relief, digestive health, dermatological drugs, oral medical care, eye care and smoking cessation. Similarly, whereas the vitamins and dietary supplements market is categorized based on point of sale into the following segments: retail pharmacies and stores, e-commerce and other points of sale; the OTC drugs market is categorized as retail pharmacies and stores as well as epharmacies.
Report Scope
- 46 data tables and 59 additional tables
- An overview of the global market for over-the-counter drugs,vitamins and dietary supplements
- An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Highlights of the current and future market potential and quantification of the market by product type, point of sales, and geographic region
- Discussion on market opportunities for over-the-counter drugs,vitamins and dietary supplement applications, industry structure, and regulatory scenarios
- Information on the latest developments in healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
- Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry, including Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer AG, and Procter & Gamble
Companies Featured
- Abbott
- Amway Corp.
- Bayer AG
- DSM-Firmenich
- Haleon Group of Co.
- Herbalife Ltd.
- Kenvue
- Nestle Health Science
- Opella Healthcare Group SAS
- Pharmavite
- Procter & Gamble
- Reckitt
- STADA Arzneimittel AG
- Taisho Pharmaceutical Holdings Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 155 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $276.9 Billion |
| Forecasted Market Value (USD) by 2030 | $371.7 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Market Definitions
- Over-the-counter (OTC) Drugs
- Vitamins and Dietary Supplements
- Industry Overview
- Macroeconomic Analysis
- Porter's Five Forces Analysis
- Bargaining Power of Buyers (High)
- Bargaining Power of Suppliers (Moderate to Low)
- Threat of New Entrants (Moderate)
- Threat of Substitutes (Low)
- Industry Competition (High)
Chapter 3 Market Dynamics
- Market Drivers
- Increasing Trend Toward Self-Care and Preventive Care
- Changing Demographics Resulting in Aging Population
- Increasing Pressure on Public Health Systems
- Premiumization and Innovation Driving Pricing
- Rising Online Sales Channels and Growth of Telehealth Platforms
- Market Restraints
- Increases in the Availability and Acceptance of Private-Label Brands
- Threat from Counterfeit Products
- Presence of Alternative Methods
- Impact of Seasonality
- Market Opportunities
- Growing Middle Class in Emerging Economies
- Growing Demand for Women's Health and Cognitive Health Support Products
- Shift Toward Herbal and Organic Products
- E-Commerce and Direct-to-Consumer Sales
- Key Takeaways
Chapter 4 Regulatory Landscape
- U.S.
- OTC Drugs
- Vitamins and Dietary Supplements
- Europe
- OTC Drugs
- Vitamins and Dietary Supplements
- Asia-Pacific
- OTC Drugs
- Vitamins and Dietary Supplements
Chapter 5 Emerging Technologies and Developments
- Increased Awareness of Ingredient Labeling
- Brand Extension Fueled by Innovation
- Rx-to-OTC Switch
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- OTC Drugs, Vitamins and Dietary Supplements Market, by Product Type
- Vitamins and Dietary Supplements
- Market Overview
- Key Takeaways
- Market Revenue and Forecast
- Vitamins and Dietary Supplements Market, by Point of Sale
- Retail Pharmacies and Stores
- E-Commerce
- Other Points of Sales
- OTC Drugs
- Market Overview
- Key Takeaways
- Market Revenue and Forecast, by Product Type
- Respiratory Treatments
- Pain Relief
- Digestive Health
- Dermatological Drugs
- Oral Medical Care
- Eye Care
- Smoking Cessation
- OTC Drugs Market, by Point of Sale
- Retail Pharmacies and Stores
- E-Pharmacies
- Geographic Breakdown
- OTC Drugs, Vitamins and Dietary Supplements Market, by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Chapter 7 Competitive Intelligence
- Key Takeaways
- OTC Drugs
- Vitamins and Dietary Supplements
- Key Developments and Strategies
Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective
- Introduction to ESG
- Environment
- Social
- Governance
- ESG Risk Ratings
- Conclusion
Chapter 9 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/cul42r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
